Fleming, T., Nissen, S. E., Borer, J. S., Armstrong, P. W., & Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration, . (2004). Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. In Circulation (Vol. 109, pp. e9004–e9005). United States. https://doi.org/10.1161/01.CIR.0000118364.89571.16

Fleming, Thomas, Steven E. Nissen, Jeffrey S. Borer, Paul W. Armstrong, and Paul W. Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration. “Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.” In Circulation, 109:e9004–5, 2004. https://doi.org/10.1161/01.CIR.0000118364.89571.16.

Fleming T, Nissen SE, Borer JS, Armstrong PW, Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration. Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. In: Circulation. 2004. p. e9004–5.

Fleming, Thomas, et al. “Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.” Circulation, vol. 109, no. 2, 2004, pp. e9004–05. Pubmed, doi:10.1161/01.CIR.0000118364.89571.16.

Fleming T, Nissen SE, Borer JS, Armstrong PW, Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration. Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. Circulation. 2004. p. e9004–e9005.